A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04256421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Tiragolumab
DRUG: Atezolizumab
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Placebo

Sponsor

Hoffmann-La Roche